Global Radioactive Glass Microsphere Market Growth 2024-2030
Radioactive glass microspheres are a substance used in medical technology. They are usually made of aluminum, silicon oxide and other materials, with a particle size of 20~30μm and a density of 3.3g/mL. These microspheres can be injected into the target tumor tissue through interventional surgery, releasing high-energy pure beta rays to radiate and kill the tumor tissue from the inside.
The global Radioactive Glass Microsphere market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Radioactive Glass Microsphere Industry Forecast” looks at past sales and reviews total world Radioactive Glass Microsphere sales in 2023, providing a comprehensive analysis by region and market sector of projected Radioactive Glass Microsphere sales for 2024 through 2030. With Radioactive Glass Microsphere sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radioactive Glass Microsphere industry.
This Insight Report provides a comprehensive analysis of the global Radioactive Glass Microsphere landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Radioactive Glass Microsphere portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Radioactive Glass Microsphere market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radioactive Glass Microsphere and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radioactive Glass Microsphere.
Radioactive glass microsphere treatment plays an important role in the treatment of liver cancer. It has good results in treating patients with liver cancer in all stages, providing new hope for liver cancer patients. In the future, radioactive glass microspheres will be used more widely.
This report presents a comprehensive overview, market shares, and growth opportunities of Radioactive Glass Microsphere market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
Size 20μm-25μm
Size 25μm-30μm
Others
Segmentation by application
Liver Cancer
Tongue Cancer
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Boston Scientific
XL Sci-Tech
BWXT
ABK Biomedical
Chengdu New Radiomedicine Technology Co.,Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Radioactive Glass Microsphere market?
What factors are driving Radioactive Glass Microsphere market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Radioactive Glass Microsphere market opportunities vary by end market size?
How does Radioactive Glass Microsphere break out type, application?
Please note: The report will take approximately 2 business days to prepare and deliver.